Skip to content

Author

M. Di Carli

6 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Nov 2026

Abstract 15941: Paired Single Cell Transcriptomics Reveals Immune Remodeling During PCSK9 Inhibition in Atherosclerotic Cardiovascular Disease

Background - Proprotein Convertase Subtilisin/Kexin Type 9 inhibitors (PCSK9i) lower LDL-C and reduce ASCVD events, but their effects on circulating immune composition and cell-specific transcriptional programs remain incompletely defined. Hypothesis: PCSK9 inhibition is associated with changes in monocyte tra...

Maanas Gupta, S. Remala, K. Marks et al. · 0 citations
Nov 2026

Abstract 8473: Vascular Dysfunction, Body Composition and Cardiovascular Outcomes in Patients with Diabetes

Background: Diabetes confers increased yet heterogeneous cardiovascular risk. Coronary microvascular dysfunction (CMD) is a robust, independent predictor of adverse outcomes and a key link between metabolic dysregulation and cardiovascular events. Excess visceral and ectopic adiposity, which are features of diabetes...

Carole Kounga, Filipe A. Moura, Lee Joseph et al. · 0 citations
Oct 2026

Prediction of All-Cause Mortality, Cardiovascular Mortality, and Angiographic Coronary Disease From LVEF Reserve: Findings From the Multicenter REFINE PET Registry.

BACKGROUND Left ventricular ejection fraction reserve (LVEF-R), defined as stress EF minus rest EF, is a marker for high-risk coronary artery disease in patients undergoing positron emission tomography myocardial perfusion imaging, but its prognostic and diagnostic significance in large real-world populations remains i...

W. Hijazi, Jian-Hang Zhou, Robert J. H. Miller et al. · 0 citations
Open access Oct 2026

Hemodynamic response to exercise and cardiovascular risk in patients with normal myocardial perfusion

A hypertensive response to exercise (HRE) has been associated with adverse cardiovascular (CV) outcomes in select populations, but its prognostic value in patients with normal myocardial perfusion remains unclear. To evaluate whether HRE is associated with incident CV events in a low-risk exercise SPECT po...

J. Lu, S. Carre, J. Hainer et al. · 0 citations
Open access Sep 2026

Artificial intelligence-derived splenic response in cardiac positron emission tomography is associated with major adverse cardiovascular events: a multi-site study.

AIMS Inadequate pharmacologic stress may limit the diagnostic and prognostic accuracy of myocardial perfusion imaging (MPI). The splenic ratio (SR), a measure of stress adequacy, has emerged as a potential imaging biomarker. We developed an artificial intelligence (AI) method to derive SR and evaluated the prognostic v...

G. Ramirez, Naga L. Dharmavaram, A. Shanbhag et al. · 0 citations
Review Open access Aug 2026

124I-Evuzamitide Positron Emission Tomography/Computed Tomography for Diagnosing Cardiac Amyloidosis: The REVEAL Nonrandomized Clinical Trial.

Results support 124I-evuzamitide PET/CT as a diagnostic test to evaluate patients with suspected cardiac amyloidosis and support 124I-evuzamitide PET/CT as a diagnostic test to evaluate patients with suspected cardiac amyloidosis.

S. Dorbala, Mathew S. Maurer, S. Cuddy et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.